Pille Taba
Pille Taba
Professor of Neurology
Verified email at
Cited by
Cited by
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
The Lancet Neurology 18 (12), 1091-1102, 2019
EFNS/MDS‐ES recommendations for the diagnosis of P arkinson's disease
A Berardelli, GK Wenning, A Antonini, D Berg, BR Bloem, V Bonifati, ...
European journal of neurology 20 (1), 16-34, 2013
EAN consensus review on prevention, diagnosis and management of tick‐borne encephalitis
P Taba, E Schmutzhard, P Forsberg, I Lutsar, U Ljøstad, Å Mygland, ...
European journal of neurology 24 (10), 1214-e61, 2017
Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
NE Mencacci, IU Isaias, MM Reich, C Ganos, V Plagnol, JM Polke, J Bras, ...
Brain 137 (9), 2480-2492, 2014
Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms
L Kadastik-Eerme, M Rosenthal, T Paju, M Muldmaa, P Taba
Health and quality of life outcomes 13, 1-8, 2015
The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection
E Moro, A Priori, E Beghi, R Helbok, L Campiglio, CL Bassetti, E Bianchi, ...
European journal of neurology 27 (9), 1727-1737, 2020
Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets
DA Kia, D Zhang, S Guelfi, C Manzoni, L Hubbard, RH Reynolds, J Botía, ...
JAMA neurology 78 (4), 464-472, 2021
Differences in MDS‐UPDRS scores based on Hoehn and Yahr stage and disease duration
M Skorvanek, P Martinez‐Martin, N Kovacs, M Rodriguez‐Violante, ...
Movement disorders clinical practice 4 (4), 536-544, 2017
Patient education in Parkinson's disease: formative evaluation of a standardized programme in seven European countries
M Macht, C Gerlich, H Ellgring, M Schradi, ÀB Rusiñol, M Crespo, A Prats, ...
Patient education and counseling 65 (2), 245-252, 2007
Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia
P Taba, M Rosenthal, J Habicht, H Tarien, M Mathiesen, S Hill, L Bero
BMC health services research 12, 1-7, 2012
A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details
M Romoli, I Jelcic, R Bernard‐Valnet, D García Azorín, L Mancinelli, ...
European journal of neurology 27 (9), 1712-1726, 2020
Leg-extension strength and chair-rise performance in elderly women with Parkinson’s disease
M Pääsuke, J Ereline, H Gapeyeva, K Joost, K Mõttus, P Taba
Journal of Aging and Physical Activity 12 (4), 511-524, 2004
H Gonzalez, IJ Koralnik, CM Marra
Seminars in neurology 39 (04), 448-455, 2019
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
KJ Billingsley, IA Barbosa, S Bandrés-Ciga, JP Quinn, VJ Bubb, ...
npj Parkinson's Disease 5 (1), 8, 2019
Manganese-induced parkinsonism due to ephedrone abuse
K Sikk, S Haldre, SM Aquilonius, P Taba
Parkinson’s Disease 2011, 2011
Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease
G Liu, J Peng, Z Liao, JJ Locascio, JC Corvol, F Zhu, X Dong, ...
Nature genetics 53 (6), 787-793, 2021
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
RH Reynolds, J Botía, MA Nalls, J Hardy, SA Gagliano Taliun, M Ryten
npj Parkinson's Disease 5 (1), 6, 2019
Irreversible motor impairment in young addicts–ephedrone, manganism or both?
K Sikk, P Taba, S Haldre, J Bergquist, D Nyholm, G Zjablov, T Asser, ...
Acta Neurologica Scandinavica 115 (6), 385-389, 2007
European academy of neurology/movement disorder society‐European section guideline on the treatment of Parkinson's disease: I. Invasive therapies
G Deuschl, A Antonini, J Costa, K Śmiłowska, D Berg, JC Corvol, ...
European journal of neurology 29 (9), 2580-2595, 2022
Psychostimulants and movement disorders
A Asser, P Taba
Frontiers in neurology 6, 127637, 2015
The system can't perform the operation now. Try again later.
Articles 1–20